Cargando…

CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis, which infects more than 23% of the world’s population. With the emergence of drug-resistant TB (DR-TB) and latent TB infection (LTBI), rapid diagnosis of DR-TB and LTBI has become a challenge for the prevention and cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Yong, Li, Kun, Li, Yuxi, Guo, Donglin, Xu, Jing, Li, Yuexi, Gong, Wenping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612056/
https://www.ncbi.nlm.nih.gov/pubmed/36297268
http://dx.doi.org/10.3390/pathogens11101211
_version_ 1784819682738438144
author Qi, Yong
Li, Kun
Li, Yuxi
Guo, Donglin
Xu, Jing
Li, Yuexi
Gong, Wenping
author_facet Qi, Yong
Li, Kun
Li, Yuxi
Guo, Donglin
Xu, Jing
Li, Yuexi
Gong, Wenping
author_sort Qi, Yong
collection PubMed
description Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis, which infects more than 23% of the world’s population. With the emergence of drug-resistant TB (DR-TB) and latent TB infection (LTBI), rapid diagnosis of DR-TB and LTBI has become a challenge for the prevention and control of TB. Herein, we highlight these challenges and discuss emerging clustered regularly interspaced short palindromic repeats (CRISPR)-based diagnostics in TB detection. Currently, the clinical diagnosis of M. tuberculosis infection mainly depends on pathogenic and molecular biological methods, including sputum smear, sputum culture, and Xpert. Although CRISPR-based diagnostics have not been applied to the clinical diagnosis of TB, they have shown exciting preponderances in TB diagnosis compared with traditional methods, including higher sensitivity, less sample input, and shorter turnaround time. CRISPR-based diagnostics represent a potential tool to address the challenges and natural weaknesses associated with traditional TB diagnosis methods. Based on the currently available data, we suggest that future CRISPR-based TB diagnostics should be developed in the direction of automation, modularization, diversification, and intelligence. By combining the CRISPR platform with various systems, such as microfluidic chips, droplet microfluidics, electrochemical techniques, and optical systems, the specificity and sensitivity of TB diagnosis may be revolutionized.
format Online
Article
Text
id pubmed-9612056
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96120562022-10-28 CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis Qi, Yong Li, Kun Li, Yuxi Guo, Donglin Xu, Jing Li, Yuexi Gong, Wenping Pathogens Commentary Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis, which infects more than 23% of the world’s population. With the emergence of drug-resistant TB (DR-TB) and latent TB infection (LTBI), rapid diagnosis of DR-TB and LTBI has become a challenge for the prevention and control of TB. Herein, we highlight these challenges and discuss emerging clustered regularly interspaced short palindromic repeats (CRISPR)-based diagnostics in TB detection. Currently, the clinical diagnosis of M. tuberculosis infection mainly depends on pathogenic and molecular biological methods, including sputum smear, sputum culture, and Xpert. Although CRISPR-based diagnostics have not been applied to the clinical diagnosis of TB, they have shown exciting preponderances in TB diagnosis compared with traditional methods, including higher sensitivity, less sample input, and shorter turnaround time. CRISPR-based diagnostics represent a potential tool to address the challenges and natural weaknesses associated with traditional TB diagnosis methods. Based on the currently available data, we suggest that future CRISPR-based TB diagnostics should be developed in the direction of automation, modularization, diversification, and intelligence. By combining the CRISPR platform with various systems, such as microfluidic chips, droplet microfluidics, electrochemical techniques, and optical systems, the specificity and sensitivity of TB diagnosis may be revolutionized. MDPI 2022-10-20 /pmc/articles/PMC9612056/ /pubmed/36297268 http://dx.doi.org/10.3390/pathogens11101211 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Qi, Yong
Li, Kun
Li, Yuxi
Guo, Donglin
Xu, Jing
Li, Yuexi
Gong, Wenping
CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis
title CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis
title_full CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis
title_fullStr CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis
title_full_unstemmed CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis
title_short CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis
title_sort crispr-based diagnostics: a potential tool to address the diagnostic challenges of tuberculosis
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612056/
https://www.ncbi.nlm.nih.gov/pubmed/36297268
http://dx.doi.org/10.3390/pathogens11101211
work_keys_str_mv AT qiyong crisprbaseddiagnosticsapotentialtooltoaddressthediagnosticchallengesoftuberculosis
AT likun crisprbaseddiagnosticsapotentialtooltoaddressthediagnosticchallengesoftuberculosis
AT liyuxi crisprbaseddiagnosticsapotentialtooltoaddressthediagnosticchallengesoftuberculosis
AT guodonglin crisprbaseddiagnosticsapotentialtooltoaddressthediagnosticchallengesoftuberculosis
AT xujing crisprbaseddiagnosticsapotentialtooltoaddressthediagnosticchallengesoftuberculosis
AT liyuexi crisprbaseddiagnosticsapotentialtooltoaddressthediagnosticchallengesoftuberculosis
AT gongwenping crisprbaseddiagnosticsapotentialtooltoaddressthediagnosticchallengesoftuberculosis